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with certain diabetes drugs. Non-severe hypoglycemic events (NSHEs)
occur more frequently than severe events and account for the majority
of total events. The objective of this multi-country study was to identify
how NSHEs in a working population affect productivity, costs, and self-
management behaviors. Methods: A 20-minute survey assessing the
mpact of NSHEs was administered via the Internet to individuals ( 18
years of age) with self-reported diabetes in the United States, United
Kingdom, Germany, and France. The analysis sample consisted of all
respondents who reported an NSHE in the past month. Topics includ-
ed: reasons for, duration of, and impact of NSHE(s) on productivity and
diabetes self-management. Results: A total of 1404 respondents were
included in this analysis. Lost productivity was estimated to range
from $15.26 to $93.47 (USD) per NSHE, representing 8.3 to 15.9 hours of
lost work time per month. Among individuals reporting an NSHE at
up, 2
al So
doi:10.1016/j.jval.2011.02.001work (n  972), 18.3% missed work for an average of 9.9 hours (SD 8.4).
Among respondents experiencing an NSHE outside working hours (in-
cluding nocturnal), 22.7% arrived late for work or missed a full day.
Productivity loss was highest for NSHEs occurring during sleep, with an
average of 14.7 (SD 11.6) working hours lost. In the week following the
NSHE, respondents required an average of 5.6 extra blood glucose test
strips. Among respondents using insulin, 25% decreased their insulin
dose following the NSHE.Conclusions: NSHEs are associated with sub-
stantial economic consequences for employers and patients. Greater
attention to treatments that reduce NSHEs could have a major, positive
impact on lost work productivity and overall diabetes management.
Keywords: cost analysis, diabetes, disease management, hypoglycemia.
Copyright © 2011, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Hypoglycemia is a common complication of treatment with an-
tidiabetic medications. Symptoms of hypoglycemia often include,
but are not limited to: pounding heart (8%–62%), trembling (32%–
78%), hunger (39%–49%), sweating (47%–84%), difficulty concen-
trating (31%–75%), and/or frank confusion (13%–53%) [1]. Accord-
ing to the American Diabetes Association, hypoglycemic episodes
are categorized as either severe (events that require the assistance
of another person to administer a remedy) or non-severe (events
that do not require assistance from another individual). These
non-severe hypoglycemic events (NSHEs) may be symptomatic
and confirmed by a low blood glucose reading. However, NSHEs
may also be asymptomatic (patient does not exhibit typical symp-
toms, but hypoglycemia is confirmed by a low blood glucose read-
ing), or probable (patient has typical symptoms, but low blood
glucose is not confirmed by a blood glucose reading) [2].
Data from multiple studies indicate that NSHEs occur in 24% to
60% of patients with diabetes. They account for 88% of total hypo-
glycemic events [3-6]. According to a retrospective study con-
ducted in Canada to examine the costs of hypoglycemia and hy-
perglycemia, NSHE management accounts for up to 13% of all
out-of-pocket costs related to diabetes [7]. In addition, approxi-
mately one-third of patients with diabetes report that NSHEs in-
terrupt and affect their ability to carry out day-to-day tasks includ-
* Address Correspondence to: Meryl Brod, President, The Brod Gro
E-mail : mbrod@thebrodgroup.net.
1098-3015/$36.00 – see front matter Copyright © 2011, Internation
Published by Elsevier Inc.ing housework, social activities, sporting activities, and sleep [8,9].
NSHEs can also affect health-related quality of life. Patients report
that fear of hypoglycemia may lead to increased panic and anxi-
ety, or deliberate overeating in order to boost blood glucose levels
[10,11]. In addition, hypoglycemic events, and concerns regarding
future events, can lead patients with diabetes to maintain higher
glucose levels overall and/or fail to use adequate doses of insulin
or oral antidiabetic medications [12–15]. Patient concerns about
potential hypoglycemia are also associated with an increased fre-
quency of self-monitoring of blood glucose [16] and an attendant
increase in blood glucose strip use [17].
Existing data indicate that NSHEs occur more frequently in in-
sulin-treated than non-insulin treated patients, are more likely to
occur on working compared with non-working days, and are as-
sociated with missed work [6,9]. Additionally, the impact on work
productivity for the majority of NSHEs which occur outside of the
work place, such as during sleep, is unknown. Data documenting
the effect of NSHEs on work productivity are limited; one 12-
month, prospective study found that, among insulin-treated pa-
tients with diabetes, up to 30% of minor hypoglycemic events oc-
cur at work [18]. Likewise, NSHEs have been shown to decrease
work productivity in individuals with type 2 diabetes. Results from
a survey-based, retrospective study (N  200) found that 6.7% to
10.3% reported leaving work/school early due to the hypoglycemic
event, and 9.3% stayed home the day after the hypoglycemic event
(type 2 diabetes only) [19].
19 Julia Avenue, Mill Valley, CA 94941 USA.
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666 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 6 6 5 – 6 7 1The objective of this multi-country study was to examine the
impact of NSHEs occurring during work, outside working hours,
and nocturnally, on productivity (both absenteeism and reduced
performance while at work) and diabetes self-management in pa-
tients with type 1 and type 2 diabetes. In order to address the
scarcity of currently available published data regarding the impact
of NSHEs, this study addresses productivity and identifies the im-
pact on work productivity for the majority of NSHEs which occur
outside of the work place, such as during sleep.
Methods
To facilitate survey development, extensive background qualitative
research was conducted using focus groups and individual telephone
interviews among a total of 68 patients in the United States, United
Kingdom, and France who had recently experienced an NSHE. As
Germany was not originally included in the countries to be surveyed,
they did not participate in the interview process. A total of eight focus
groups were conducted, consisting of individuals aged 18 years
ith type 1 or type 2 diabetes, who reported experiencing1 NSHE in
he past 3 months. Topics discussed, from a patient perspective, in-
luded how NSHEs impact daily life, functioning, and well-being, as
ell as diabetes treatment and self-management.
Feedback received from these interviews was combined with a
eview of the current literature and expert input, and a survey was
eveloped to assess the impact of NSHEs on work productivity and
iabetes self-management. The survey (in English) was then cog-
itive-debriefed and pilot-tested in six additional patients. These
teps were undertaken to ensure content validity (relevant ques-
ions) and face-validity with respondents (i.e., no unfamiliar/
trange words or concepts). After six interviews there were no
ignificant changes to the survey required and debriefing was con-
luded. The final questionnaire was translated into all relevant
anguages using a linguistic validation method [20].
The survey was administered in the United States, United
ingdom, Germany, and France via a secure Internet server. Re-
pondents were selected by applying a sampling frame to a pre-
xisting panel of individuals with self-reported type 1 or 2 diabe-
es. In order to ensure the generalizability of the results from the
anel, the panel structure and recruitment used the following strat-
gies. The panel used for the survey was multisource: panellists were
ainly recruited online via a wide range of permission, e-mail re-
ruitment, affiliate networks and web site advertising, avoiding po-
ential bias associated with single source recruitment methodology.
atients were recruited from literally hundreds of web sites as well as
rom face to face and telephone surveys where appropriate to in-
lude members who were not frequent online users. Additionally,
he panel was used for research only. Panelists were not exposed to
hird party advertising or direct marketing campaigns, nor were their
ersonal data sold to third parties. The panel was also frequently
efreshed to ensure that the panel was dynamic in nature and re-
ected any changes in the online population that may have been
ccurring. Lastly, the incentive was very low to help ensure that there
as not undue incentive to participate in the panel.
All respondents were required to first respond to a healthcare
rofiler (screening) to ensure that their diabetes had been diag-
osed by a physician, and that diabetes treatment had been initi-
ted. In addition, eligible respondents were required to be 18
ears of age, able to read in the predominant language of their
ountry of residence, and to have experienced1 NSHE in the past
onth (to reduce recall bias, a maximum of 1-month recall was
pplied). During the survey, respondents answered questions re-
arding what they perceived to have caused the hypoglycemic
vent, the duration of the event, and the impact of the NSHE on
roductivity. The survey took approximately 20 minutes to com-
lete and respondents were remunerated the equivalent of $10.00
S dollars (USD) for completing the survey.A stratified sampling procedure (to account for disproportion-
te response rates between stratification categories) was applied
o ensure adequate sample size in relevant subcategories. This
ncluded extending a survey invitation to individuals who ex-
ressed interest in participating and met the criteria for an un-
lled stratification category. Stratification variables applied were:
ge (18-29 years, 30-49 years, 50-64 years, and  65 years) and
iabetes type (type 1 diabetes and type 2 diabetes). Based on cur-
ent guidelines [2], NSHEs were defined as a hypoglycemic situa-
ion in which the patient had low blood glucose, but did not re-
uire help from anyone else to manage the episode. Respondents
ere also permitted to classify events as NSHEs if they had hypo-
lycemic symptoms such as sweating and/or confusion, with or
ithout confirmatory blood glucose measurements, or if they ex-
erienced no symptoms, but noted a hypoglycemic episode when
ecording blood glucose levels.
The time/place of the NSHE was classified as follows: a) at
ork, b) during sleep, or c) or during the day, but not at work. In
ddition, the survey incorporated several real-time validation
teps (e.g., it affirmed any responses, such as patient age, that fell
utside the plausible minimum-maximum input values) and used
kip-patterns based on respondent replies.
Results by country are presented via frequencies or descrip-
ives (means and standard deviations) with differences explored
sing analysis of variance (ANOVA) for continuous variables and
hi square for proportions. Responses for amount of work time
ost contained outliers, or observations that appeared to be incon-
istent with other observations in the data set. To account for
hese departures from normality, a 5% trim was employed [21].
Prior to conducting the focus groups, ethics approval was re-
eived from New England IRB (approval # 08-288) for the patient
nterview and focus group portion of the study groups and from
ndependent Review Consulting (approval #09033-01) for the sur-
ey panel portion of the study. Questions on ethnicity were re-
oved from the German survey.
Results
Respondent characteristics
A total of 6756 respondents with self-reported diabetes were
screened. Of these, 2669 reported an NSHE during the last month;
54% of these individuals (n 1431) reported working for pay. Finally,
27 subjects (24 subjects listed “other” and 3 reported, “I don’t remem-
ber”) were removed from the analysis because their work status was
unable to be classified; this left 1404 respondents in the analysis.
For most demographic variables (Table 1), no substantial dif-
ferences were observed across the total sample for key variables
(e.g., percentage of respondents who used oral vs. insulin treat-
ment or had type 1 vs. type 2 diabetes). Significant cross-country
differences, however, were found for age (ANOVA, P 0.001), gen-
er (chi-square, P  0.001), and diabetes duration (ANOVA, P 
0.001). The United States had the highest mean respondent age
(49.4  13.2) and France had the youngest mean age (37.6  12.3).
The greatest percentage of females was found in the United States
(64.1%), whereas Germany had the smallest proportion of females
(42.8%). The mean duration of diabetes was longest in the US (15.8
years, SD 12.7) and shortest in Germany (8.5 years, SD 7.7).
Fifty-one percent of individuals with type 1 diabetes (range:
43.3% in Germany, 64.5% in the United States, P 0.001) and 28.4%
of individuals with type 2 diabetes (range: 24.9% in the United
States, 30.1% in France, P 0.607) reported having an NSHE at least
weekly. Eighty percent of respondents (n 1,123) reported having
an NSHE within the last 2 weeks. A total of 69.2% (n 972) respon-
dents reported having an NSHE at work in the past month. A total
of 75.0% (n  1053) reported having an NSHE during the day, but
not at work, and 44.2% (n  620) reported having an NSHE during
a
p
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some respondents experienced multiple NSHEs. When looking
only at the most recent NSHE, 34.0% of respondents reported that
the event occurred at work, 48.9% indicated during the day, but not
at work, and 16.6% reported during sleep at night.
Most documented NSHEs (60%) were symptomatic and con-
firmed by a blood glucose test. The majority of respondents (94.8%)
identified their NSHE through hypoglycemic symptoms (con-
firmed or unconfirmed by blood glucose test). A small proportion
(range 12.5%–17.1%) had no symptoms, but identified their NSHE
solely using blood glucose testing. The percent of asymptomatic
events per country were: United States – 16.9%, United Kingdom –
12.5%, Germany – 12.7%, and France – 17.1%. The primary self-
reported causes for NSHEs were irregular or insufficient food in-
take or diet (48.2%), physical exercise or overexertion (34.1%),
and/or stress (32.0%). Among respondents who reported inten-
tionally trying to lower their blood glucose levels as causative, a
miscalculated insulin dose (16.7%) or general poor control (11.4%)
were the most commonly reported events.
Impact of NSHEs on diabetes management
Respondents reported that their NSHEs lasted an average of 33.0
minutes (SD 60.6). As shown in Table 2, across all respondents
the predominant strategy for managing the most recent NSHE
Table 1 – Demographic characteristics.
Total
Sample size with NSHE within last month (N) 1404
Age, mean (SD) 42.4 (13.9)
Gender: Female, N (%) 755 (53.8%
Ethnicity, N (%)
White/Caucasian 1046 (89.6%
Latino/Hispanic/Mexican American 50 (4.3%)
Black/African American 29 (2.5%)
Other (Asian/American Indian/Mixed Race) 43 (3.7%)
Missing 236 (16.8%
Type of diabetes
Type 1, N (%) 713 (50.8%
Type 2, N (%) 691 (49.2%
Diabetes duration (years), mean (SD) 12.1 (12.4)
Diabetes treatment, N (%)
Insulin 1024 (72.9%
Orals 380 (27.1%
Hours worked per week, mean (SD) 34.6 (11.8)
Status when last NSHE happened, N (%):
Awake, and at work 484 (34.5%
Awake, but not at work 687 (48.9%
During sleep at night 233 (16.6%
Last NSHE was, N (%):
Symptomatic, confirmed by blood glucose test 875 (62.3%
Symptomatic, not confirmed by blood glucose test 457 (32.5%
No symptoms, but confirmed by blood glucose test 72 (5.1%)
Frequency of NSHE, N (%)
Type 1
“Daily” to “about 1/week” 365 (51.2%
“1/month” to “several times/month” 193 (27.1%
“Only a few times/year”/“very rarely” 155 (21.7%
Type 2
“Daily” to “about 1/week” 196 (28.4%
“1/month” to “several times/month” 234 (33.9%
“Only a few times/year”/“very rarely” 261 (37.8%
NSHE, non-severe hypoglycemic event; SD, standard deviation.
* Analysis of variance (ANOVA).
† Chi square.was the use of sugar drinks and packs. Approximately one-third (of the total sample (range 25% Germany to 43% United States)
also ate a meal to deal with their event. In the week following the
event, compared with usual blood glucose monitoring practices,
respondents conducted an average 5.6 (SD 8.5) extra self-monitor-
ing tests. Additionally, 24.9% of the sample contacted a health-
care professional (either primary care physician, hospital, diabe-
tes clinic, or other health-care worker) as a result of the event.
Last, among respondents using insulin, 25% reported decreasing
their insulin dose following their NSHE. The average decrease was
6.5 (SD 13.1) insulin units for an average of 3.6 (SD 5.1) days.
Impact on productivity of NSHEs occurring during working hours
Of the total sample reporting an NSHE at work during the past
month (n 972), 9 patients (4.9%) were removed from this analysis
as outlying data (5% upper-limit trim). As shown in Table 3, among
the 963 evaluated respondents, 18.3% (n  176) either left work
early or missed a full day. For NSHEs occurring during work hours,
the average time lost from work was 9.9 hours (SD 8.4). In addition,
23.8% (n 231) of respondents reported missing a meeting or work
ppointment, or not finishing a work task on time. The number of
eople who missed work or a meeting/appointment due to their
SHE was significantly greater in the UK (23.3%) and France
USA UK Germany France P value
409 385 236 374
9.4 (13.2) 40.4 (13.8) 41.2 (13.2) 37.6 (12.3) 0.001*
62 (64.1%) 180 (46.8%) 101 (42.8%) 212 (56.7%) 0.001†
60 (88.0%) 345 (89.6%) NA 341 (91.2%) 0.142†
17 (4.2%) 15 (3.9%) NA 18 (4.8%)
17 (4.2%) 8 (2.1%) NA 4 (1.1%)
15 (3.7%) 17 (4.4%) NA 11 (2.9%)
0 (0.0%) 0 (0.0%) 236 (100%) 0 (0.0%)
00 (48.9%) 193 (50.1%) 120 (50.8%) 200 (53.5%) 0.630†
09 (51.1%) 192 (49.9%) 116 (49.2%) 174 (46.5%)
5.8 (12.7) 11.9 (11.2) 8.5 (7.7) 10.5 (14.4) 0.001*
90 (70.9%) 279 (72.5%) 175 (74.2%) 280 (74.9%) 0.619†
19 (29.1%) 106 (27.5%) 61 (25.8%) 94 (25.1%)
4.2 (13.4) 33.2 (12.2) 35.8 (12.1) 35.6 (8.7) 0.013*
23 (30.1%) 111 (28.8%) 73 (30.9%) 177 (47.3%) 0.001†
04 (49.9%) 207 (53.8%) 129 (48.9%) 147 (39.3%)
82 (20.0%) 67 (17.4%) 233 (16.6%) 50 (13.4%)
70 (66.0%) 238 (61.8%) 146 (62.3%) 221 (59.1%) 0.102†
12 (27.4%) 128 (33.2%) 83 (35.2%) 134 (35.8%)
27 (6.6%) 19 (4.9%) 7 (3.0%) 19 (5.1%)
29 (64.5%) 91 (47.2%) 52 (43.3%) 93 (46.5%) 0.001†
47 (23.5%) 54 (28.0%) 32 (26.7%) 60 (30.0%)
24 (12.0%) 48 (24.9%) 36 (21.7%) 47 (23.5%)
52 (24.9%) 52 (27.1%) 33 (28.4%) 59 (33.9%) 0.607†
73 (34.9%) 69 (35.9%) 40 (34.5%) 52 (29.9%)
84 (40.2%) 71 (37.0%) 43 (37.1%) 63 (36.2%)4
) 2
) 3
)
) 2
) 2
1
) 2
) 1
3
) 1
) 2
)
) 2
) 1
) 1
)
)
)
)
)27.2%) than in Germany (8.8%) or the US (10.8%).
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hours
NSHEs that occurred outside working hours also had an impact on
respondents’ work productivity, and resulted in both absenteeism
and reduced productivity while at work. Among respondents ex-
periencing a nocturnal NSHE, 22.7% (139 of 612) arrived late for
Table 2 – Diabetes management after last NSHE.
Total
Used to recover from last NSHE, N (%)
Glucose tablets or gel 295 (21.0%) 9
Sugar packs, candy or cake 373 (26.6%) 8
Soda, juice, sweet tea or milk 421 (30.0%) 14
Light meal (e.g. sandwich) 324 (23.1%) 11
Full meal (e.g. lunch or dinner) 150 (10.7%) 5
Other 66 (4.7%) 2
Number of extra blood sugar tests after
last NSHE, mean (SD)
First day (day of NSHE) 1.9 (2.9) 1.
Second day 1.1 (2.5) 0.
Third day 0.8 (2.8) 0.
Fourth to seventh day 2.2 (5.2) 1.
Total (7 days after NSHE) 5.6 (8.5) 3.
Contacted a health-care professional† after
last NSHE
Yes, N (%) 349 (24.9%) 5
Did your LAST NSHE cause you to decrease
your normal insulin dose?
Yes, N (%) 351 (25.0%) 10
Total units decreased, mean (SD) 6.5 (13.1) 6.
Days decreased, mean (SD) 3.6 (5.1) 4.
NSHE, non-severe hypoglycemic event; SD, standard deviation.
* Chi square.
† Primary care doctor, hospital, diabetes clinic, other.
‡ Analysis of variance (ANOVA).
Table 3 – Productivity impact of an NSHE.
Total
NSHE during working hours, N (with 5% trim)* N  963
Missing work time, N (%) 176 (18.3%
If missing work time, what was the amount of
work time lost, mean (SD)
9.9 (8.4)
Missing a meeting/appointment or not finishing a
project in due time because of the NSHE, (N) %
231 (23.8%
NSHE outside working hours, N (with 5% trim)† N  1046
Missing work time, N (%) 150 (14.3%
If missing work time, what was the amount of
work time lost, mean (SD)
12.6 (11.0)
Missing a meeting/appointment or not finishing a
project in due time because of the NSHE, N (%)
173 (16.4%
Nocturnal NSHE, N (with 5% trim)‡ N  612
Missing work time, N (%) 139 (22.7%
If missing work time, what was the amount of
work time lost, mean (SD)
14.7 (11.6)
Missing a meeting/appointment or not finishing a
project in due time because of the NSHE, N (%)
197 (31.8%
NSHE, non-severe hypoglycemic events.
* The top 5% was trimmed for these results. This dropped 9 patients
† The top 5% was trimmed for these results. This dropped 7 patients
‡ The top 5% was trimmed for these results. This dropped 8 patients
§ Chi square.
 Analysis of variance (ANOVA).work or missed a full day of work (Table 3). For those reporting
missed work, an average of 14.7 working hours (SD 11.6) were lost
(after applying a 5% trim of upper outliers). In addition, 31.8% (197
of 612) of respondents reported that they missed a meeting or
work appointment or did not finish a work task on time due to the
nocturnal NSHE.
UK Germany France P value
2%) 94 (24.4%) 44 (18.6%) 62 (16.6%) 0.028*
5%) 66 (17.1%) 65 (27.5%) 158 (42.2%) 0.001*
5%) 113 (29.4%) 66 (28.0%) 97 (25.9%) 0.026*
9%) 98 (25.5%) 45 (19.1%) 63 (16.8%) 0.001*
9%) 31 (8.1%) 14 (5.9%) 48 (12.8%) 0.002*
%) 23 (6.0%) 4 (1.7%) 11 (2.9%) 0.005*
) 1.8 (1.9) 1.8 (1.6) 2.1 (3.9) 0.173
) 1.1 (1.7) 0.9 (1.4) 1.4 (2.1) 0.017
) 0.8 (1.5) 0.7 (1.2) 1.1 (2.2) 0.251
) 2.5 (6.3) 1.8 (4.2) 3.1 (5.7) 0.001
) 6.2 (9.7) 5.1 (7.5) 7.3 (9.1) 0.001
7%) 99 (25.7%) 56 (23.7%) 138 (36.9%) 0.001*
7%) 101 (26.2%) 33 (14.0%) 108 (28.9%) 0.001*
) 6.2 (9.9) 6.5 (9.3) 6.8 (19.4) 0.988‡
) 3.1 (4.2) 3.1 (4.8) 3.2 (4.0) 0.062‡
USA UK Germany France P value
N  278 N  232 N  170 N  283
30 (10.8%) 54 (23.3%) 15 (8.8%) 77 (27.2%) 0.001§
0.2 (9.5) 11.4 (9.2) 8.3 (7.1) 8.9 (7.6) 0.467
48 (17.2%) 68 (28.8%) 29 (17.0%) 86 (30.1%) 0.001§
N  307 N  287 N  173 N  279
26 (8.5%) 41 (14.3%) 14 (8.1%) 69 (24.7%) 0.001§
1.1 (10.5) 15.1 (13.6) 9.2 (7.4) 12.4 (9.9) 0.268
39 (12.7%) 49 (17.0%) 17 (9.7%) 68 (24.2%) 0.001§
N  205 N  153 N  88 N  166
29 (14.1%) 43 (28.1%) 14 (15.9%) 53 (31.9%) 0.001§
4.3 (11.8) 14.2 (10.2) 12.5 (12.7) 15.9 (12.5) 0.787
48 (23.3%) 62 (40.3%) 20 (22.2%) 67 (39.4%) 0.001§
m the USA, 4 from the UK, 1 from Germany, and 3 from France).
m the UK, 3 from Germany, and 2 from France).
m the USA, 1 from the UK, 2 from Germany, and 4 from France).USA
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but not during sleep, 14.3% (150 of 1046) reported absenteeism
from work. For respondents who reported missed work, an aver-
age of 12.6 (SD 11.0) working hours were lost (using a 5% trim).
Moreover, 16.4% (173 of 1046) reported that they missed a meeting
or work appointment or did not finish a work task on time. No
significant differences related to NSHE timing and work time lost
were observed between any countries.
Economic burden of NSHEs
The human capital method, which uses average wages to estimate
productivity, was applied to draw cost estimates for NSHEs [22].
Based on respondents’ self-reported working hours, an average of
35 working hours per week over an estimated 47 working weeks
per year (a total of 1,645 working hours per year) was used for the
calculations. The 2009 gross domestic product per capita [23] was
used to estimate annual income. An average income of $28.2 USD/
hour in the United States, $21.5 USD/hour in the United Kingdom,
$19.9 USD/hour in France, and $20.8 USD/hour in Germany [23]
were used to estimate the value of lost productivity. The conver-
sion of Euros and British Pounds to US dollars was based on the
April 9, 2010 conversion rate (1 € to 0.747 USD, 1£ to 1.54 USD).
As shown in Table 4, the estimated productivity loss per NSHE
ue to absenteeism ranged from $26.43 to $55.16 (USD) in the
nited States, $46.30 to $83.59 (USD) in the United Kingdom, $15.26
o $35.58 (USD) in Germany, and $48.33 to $93.47 (USD) in France.
hese estimates were calculated based on the proportion of respon-
ents reporting missed work, multiplied by hourly income and hours
issed. For example, for an NSHE occurring during working hours in
he US, 10.8% of the sample reported missing an average of 10.2 hours
f work at a cost of $28.2/hour (equivalent to approximately $31.12 in
roductivity loss per NSHE). An estimation of the yearly costs for
Table 4 – Productivity loss* of an NSHE.
USA
NSHE outside working hours $, (SD), N 26.43 (121.26)
N  307
NSHE at work $, (SD), N 31.12 (124.91)
N  278
NSHE at sleep at night $, (SD), N 55.16 (184.17)
N  205
NSHE, non-severe hypoglycemic event.
* Costs provided in US dollars (USD).
Table 5 – Monthly out-of-pocket costs.
Total U
Total out of pocket costs, $,* (SD), N $ 25.29 (30.74)
N  1044
$ 35.5
N
Extra/special groceries $ 21.48 (21.84)
N  375
$ 32.9
N
Food or drink from vending machines
or café/restaurants
$ 7.29 (7.75)
N  609
$ 7.8
N
Glucose products such as tablets, gum,
gel tubes, etc.
$ 8.24 (8.44)
N  513
$ 8.8
N
Extra test strips, lancets $ 17.23 (19.51)
N  385
$ 23.5
N
Using a taxi, bus or other transportation $ 19.43 (19.10)
N  143
$ 35.8
N
Other (specify) $ 8.33 (11.95)
N  32
$ 12.5
N* Costs provided in US dollars (USD).hese events, based on the number of reported events per month, is
2,293.81 (range $1,939.06–$2,986.28). Overall, NSHEs were most
ostly in France, and in each country, observed costs associated with
ost productivity were the highest for NSHEs that took place during
leep (i.e., nocturnal hypoglycemia).
Out-of-pocket costs
Respondents also reported their out-of-pocket costs required to
manage or prepare for NSHEs (Table 5). The total average monthly
out-of-pocket cost was $25.29/month, with US patients spending
the most ($35.36) and the UK patients spending the least ($16.94).
The largest expenses were extra/special groceries, extra test strips
and lancets, and transportation services.
Discussion
This study confirms prior research indicating that mild to moder-
ate hypoglycemic episodes are common in patients with both type
1 and type 2 diabetes [3,4,24,25], and are associated with substan-
tial additional costs that are borne by patients and/or payers [7,26].
The current results also validate existing data indicating that pa-
tients who have experienced NSHEs fear future hypoglycemic events
[14,19], and that NSHEs are associated with patient-initiated changes
to diabetes self-management. These include an increased frequency
of SMBG (self-monitoring of blood glucose) testing and greater use of
blood glucose strips [16,17], as well as adjustments to insulin dose
and/or increased food consumption [19]. In this study, across all four
countries, costs for extra blood glucose strips, as well as patient out-
of-pocket expenses for food items to control NSHEs, ranged from
$17 to $35 USD. The number of extra blood glucose tests per NSHE
was estimated to range from 3.9 to 7.3.
UK Germany France P value
(157.60)
 287
15.50 (67.24)
N  173
61.12 (144.41)
N  279
0.001
(140.51)
 232
15.26 (65.16)
N  170
48.33 (111.58)
N  283
0.001
(177.30)
 153
35.58 (130.27)
N  88
93.47 (197.62)
N  166
0.002
UK Germany France P value
.04) $ 16.94 (23.36)
N  299
$ 22.71 (25.50)
N  178
$ 24.91 (30.37)
N  269
0.001
.25) $ 12.38 (12.45)
N  121
$ 19.59 (16.41)
N  51
$ 21.55 (20.30)
N  99
0.001
4) $ 5.33 (6.47)
N  195
$ 7.70 (7.52)
N  93
$ 9.09 (8.12)
N  138
0.001
1) $ 5.79 (8.33)
N  165
$ 8.46 (7.53)
N  85
$ 11.01 (9.38)
N  104
0.001
.40) $ 8.01 (12.50)
N  85
$ 17.81 (17.79)
N  59
$ 14.07 (16.09)
N  82
0.001
.32) $ 11.97 (13.13)
N  67
$ 20.95 (18.26)
N  26
$ 26.39 (21.59)
N  38
0.001
.16) $ 7.53 (11.38)
N  12
$ 2.69 (2.72)
N  5
$ 4.23 (3.02)
N  3
0.41046.30
N
57.21
N
83.59
NSA
6 (37
 298
4 (28
 104
3 (8.4
 183
6 (7.7
 159
8 (22
 159
3 (23
 12
0 (15
 12
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cating that NSHEs have a substantial effect on productivity [5,19].
Across the four countries evaluated, a high proportion of respon-
dents reported missed work time due to NSHEs (mean hours lost
per incident ranged from 8.3 to 15.9). Using a human capital ap-
proach, the lost productivity per NSHE was estimated to range
from $15.26 to $93.47 USD. Of interest, nocturnal hypoglycemia,
the least-frequently reported NSHE type (occurring in 44.2% of re-
spondents vs. 70.0%–75.0% of respondents reporting daytime
events), was associated with the highest per-incident work time
lost and costs for lost productivity.
Compared with existing research, the current findings appear
to contradict only those obtained by Leckie and colleagues [18] in a
2005, 12-month, UK based prospective evaluation of 243 employed
individuals with insulin-treated diabetes. In this study, among pa-
tients who experienced mild (defined as self-treated) hypoglyce-
mia at work (563 events), only 19 individuals reported requiring
time off from work (mean time off: 12.8 minutes; maximum time
off: 30 minutes). The definitions applied in this study to distin-
guish mild from severe hypoglycemia, however, were not as strin-
gent as those used in the current research, and moderate hypogly-
cemia was not defined at all. Furthermore, this study only
evaluated the productivity impact of hypoglycemic events that
took place at work.
As with all research, this study was not able to address or an-
swer the wide range of important issues regarding the impact of
NSHEs. We suggest that future research in this area is needed. As
reported here, there are country differences in important demo-
graphic factors that may impact outcomes. For example, do pa-
tients with diabetes for a longer duration of time adjust their man-
agement differently than those newly diagnosed? Are patients
using insulin pumps more or less impacted by NSHEs? Additional
research is also needed to better understand the impact of socio-
cultural factors and country differences which were identified in
this study. It is of note that the productivity impact on employers
of NSHEs during working hours varies by country, but the impact
of NSHEs outside working hours does not. This suggests that the
influence of country-specific work place ethics and standards war-
rants greater examination. Can the finding that the impact of work
place NSHEs is greater in the United Kingdom and France than in
the United States and Germany be due to a greater tolerance for
work place absence in the United Kingdom and France? Further,
what is the impact of nocturnal NSHEs, as lost productivity costs
were the highest for events occurring while asleep in every coun-
try? The burden of illness for nocturnal NSHEs warrants consider-
able focus in future research as does the clinical implications and
impact of reduced insulin use following an NSHE on the course of
disease and treatment compliance. The clinical implication of re-
duced insulin use following an NSHE by a quarter of patients sug-
gests that patient’s trade-off adequate glycemic control to avoid
future hypoglycemic events. Inclusion of this information in both
patient diabetes education and discussion between patients and
their physicians may be beneficial.
Several limitations of this study should be mentioned. First,
since recall bias can influence findings, accuracy of reporting is a
consideration with any survey research project. A 1991 study com-
paring prospective and retrospective recordings of hypoglycemic
episodes, however, found no statistically significant difference be-
tween the accuracy of prospectively and retrospectively recorded re-
cordings, and concluded that recall of up to 1 week could be consid-
ered relatively accurate [6]. In the case of this study, based on findings
obtained from focus groups conducted prior to survey implementa-
tion, recall was posited to be accurate for up to 1 month.
It is also feasible that data collection via an Internet-based sur-
vey could introduce selection bias, since only literate respondents
with computer access were able to participate. The literacy rates
and proportion of Internet users in all four sampled countries,however, are high (e.g., the United Kingdom has a 99% literacy rate
and 48.7 million computer users out of 61.1 million inhabitants)
[23]. Accuracy could also be affected by the incentive administered
to respondents for completion of the survey. However, the amount
of the incentive was minimal (approximately $10 USD) and should
not have affected participant response. In addition, because all
countries that participated in the study were in Western Europe or
North America, it is not certain whether a similar study, con-
ducted in countries with different cultures or diabetes manage-
ment systems, would yield the same results.
Another consideration is that this survey was not designed to
adequately capture the extent of respondent contact with health-
care professionals following an NSHE. For example, the survey did
not distinguish between actual visits and telephone consultations,
and respondents could report both scheduled and unscheduled
contacts (although only unscheduled visits would incur extra
costs). If available, such data might add to the cost equation iden-
tified by this study, and future research should be considered to
examine the increased costs associated with contacting health
professionals following an NSHE. Also, given the panel nature of
the survey it was not possible to have a physician confirmed diag-
nosis. However, it was not known to the patients who completed
the screener beforehand that only those with diabetes would be
administered the survey. In the screener, the subjects were pro-
vided with several medical conditions and asked to check which
they had been diagnosed with by a physician. Only those who
checked diabetes, among the multiple possibilities, were invited to
complete the full survey. Additionally, only a small incentive was
given to complete the survey. Given these safeguards, we believe
that the incidence of misrepresentation of diagnosis was unlikely
and that this group was not large enough to influence findings.
Lastly, the current study may underestimate the full extent of
the burden of NSHEs on work productivity from the patient per-
spective because NSHEs not only affects absenteeism, but the abil-
ity to be productive while at work (presenteeism), and the effects
of presenteeism were not completely captured with the current
study design. The extrapolated yearly costs for these events were
in the range of $1,939.06 to $2,986.28 USD per patient. The impli-
cations for the impact of these costs should be evaluated within
the context of the costs of goods and services and purchasing
power within each country.
From the employer perspective, these costs may be overes-
timated as the human capital cost approach does not take into
consideration the ability of the employer to have another em-
ployee accomplish the work [27]. Calculations using the friction
cost method in future studies would be of value to address this
issue.
The goal of new drugs and devices for diabetes treatment is to
improve glycemic control and reduce the frequency of adverse
events such as hypoglycemia [2]. Clearly, addressing NSHEs
should be a factor considered in this goal. Discussing NSHEs at
regular diabetes health care visits, and reviewing with patients
how to recognize NSHEs and appropriately treat and deal with
their sequelae would be a beneficial addition to routine care and
diabetes management. In addition, antidiabetic therapies that are
not associated with additive hypoglycemic risk could have a sub-
stantial impact on the individual burden imposed by such events.
As our survey indicates, NSHEs are associated with measurable
productivity and financial consequences for patients and employ-
ers. Diabetes management strategies and/or treatments that re-
duce NSHEs may have a major impact on reducing costs of care
and lost work productivity while increasing psychological health,
and daily functioning in individuals with diabetes.
Source of financial support: This study was funded by Novo
Nordisk.
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